Our team goal aligns with our company goal – to save lives and reduce the suffering caused by HAIs. We meet that goal by using evidence-based practices to deploy and assess the use of our products in the healthcare environment.


All our customers have access to the science team for a variety of services, consultation and other needs. Here is a list of some of the things we have done for customers in the past:

            • High-level meetings with facility CMO, CNO and others
            • Statistical analysis of HAI rate data
            • Statistical analysis of environmental data
            • Design of environmental/outcome studies
            • Recommendations for overall SSI improvement
            • Infection control audits
            • Review of data and recommendations





Dr. Stachowiak is a Founder of Xenex, and as its Chief Epidemiologist, she is responsible for efficacy reporting, monitoring, evaluation and data quality assurance with a focus on statistical validity. She establishes and recommends protocols for healthcare facilities utilizing Xenex’s technology, and evaluates their infection control results – helping them achieve maximum results utilizing Xenex’s recommended best practices standards. Dr. Stachowiak also oversees research study design, grant application and manuscript preparation, frequently in conjunction with Xenex’s customers. Dr. Stachowiak is an infectious disease epidemiologist who received her doctoral degree at the Johns Hopkins School of Public Health. She has been involved in research and program implementation in Russia and the former Soviet Union since 1993, including NIH, USAID and Global Fund research. She also holds Masters degrees in Public Health and International Affairs from Columbia University. In 1993, Dr. Stachowiak co-founded AIDS infoshare, a Russian organization committed to lessening the suffering caused by HIV/AIDS. From 2003-2005, she was a member of the faculty of the Johns Hopkins School of Public Health.


Dr. Stibich is a Founder of Xenex, and as its Chief Scientific Officer, he oversees scientific research, product development, facility assessments, and protocol design. He leads new technology development and is an inventor on multiple patents. Dr. Stibich meets frequently with infection prevention representatives at healthcare facilities, helping them understand and solve their infection control problems while analyzing hospital results. He has conducted CEU sessions for APIC chapters and presented at SHEA and AHE conferences, and is regarded as a thought leader in the infection control community. Dr. Stibich holds a doctoral degree from the Johns Hopkins University School of Public Health, a Masters in Health Science, also from Johns Hopkins, and a bachelor’s degree from Yale University. He has conducted research in Russia, Tajikistan, Afghanistan, South Africa, Kenya, the United States and Brazil.


As an epidemiologist, Sarah Simmons works with customers to implement Xenex technology in their facility, and provide support for the Infection Prevention departments. Sarah is a Doctoral Candidate at the University of Texas School of Public Health, has a Masters of Public Health in Epidemiology and Biostatistics from the Texas A&M School of Rural Public Health, and a Bachelors in Biology from Texas A&M University. Sarah worked as an Infection Prevetionist for five years in San Antonio, with a focus on infection prevention in critical care. Sarah is a member of the San Antonio APIC chapter and has served on the board in numerous roles.


Maria Rodriguez has joined the Science Team as a Clinical Support Manager. She has more than 30 years experience in healthcare. Maria has a Bachelor of Science Degree in Nursing, is dually licensed as a Registered Nurse in Texas and Ohio and is certified in Infection Control. She has worked as an Infection Preventionist for more than fifteen years in Ohio and San Antonio, Texas in acute care facilities. Maria a member of APIC, AORN and IAHCSMM.


Have an Infection Prevention question? Thinking about bacteria, pathogens and want to share? Talk to us at ip@xenex.com